EMILY HOFFMAN: Open Payments
NPI 1386905040 · SOMERSET, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,848 in 101 payments from 13 companies in 2025. Trend: 2023 $1,264 · 2024 $925 · 2025 $1,848
Food & beverage: $1,736Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $415 |
| Otsuka America Pharmaceutical, Inc. | 16 | $295 |
| Alkermes, Inc. | 13 | $213 |
| Teva Pharmaceuticals USA, Inc. | 5 | $172 |
| Janssen Pharmaceuticals, Inc | 9 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $149 |
| Indivior Inc. | 6 | $131 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Lundbeck LLC | 4 | $69 |
Products named: VRAYLAR, REXULTI, ARISTADA, CAPLYTA, SUBLOCADE, INVEGA SUSTENNA, SPRAVATO, Auvelity.
Industry payments across PA — which companies pay providers there.
